Friday, 19 October 2012

What can you do to keep your eyes healthy?

What can you do yourself to keep your eyes healthy?

Here are some ideas:

  • Drink sufficient amounts of water, particularly during times of stress and in old age
  • Spend plenty of time outside in fresh air
  • Avoid smoke-filled rooms
  • Get an air moisturiser when the central heating is on and the air indoors is too dry
  • Protect your eyes from draughts, wind and too much sun, perhaps by using goggles or sun glasses
  • Give your eyes time to rest and blink while working at a computer screen
  • In the evening, carefully remove all make-up from your eyes
  • Have your eyes checked regularly to ensure there are no serious underlying causes, and to keep your prescription glasses or contact lenses up-to-date
  • Regularly clean and change your contact lenses
  • A healthy diet will be good for your eyes, too

An eye lubricant may also be helpful. Solutions containing sodium hyaluronate can be particularly effective and are well tolerated. Sodium hyaluronate is an important component of healthy eyes. (Click here to read more about sodium hyaluronate).

Ask your GP, optometrist (optician), or ophthalmologist, whether you might suffer from a breakdown of the tear film, and what he might recommend to reduce your discomfort.

Sodium hyaluronate: an important component of a healthy tear film!

Friday, 10 August 2012

New Treatment of Tendon Disorders: Ostenil Tendon

New Product Launch: OSTENIL® TENDON

For the treatment of pain and reduced mobility
due to tendinopathy
TRB Chemedica (UK) Ltd have today announced that they have taken the successful OSTENIL® range concept into a new realm: that of the treatment of tendon disorders. OSTENIL® TENDON is a visco-elastic solution of 2% hyaluronic acid and 0.5% mannitol for peritendinous or intrasheath injection, and is designed to restore tendon function, by reducing pain and improving tendon mobility.

How does OSTENIL® TENDON work? The macro-molecular characteristics of sodium hyaluronate, already proven in their effectiveness in osteo-arthritis, increase the gliding effect and reduce adhesions – the tendon functions again as it is fully lubricated. At the same time sodium hyaluronate blocks the pain receptors and inhibits the movement of inflammatory mediators. This prevents the inflammation from getting any worse.
OSTENIL® TENDON is presented in a pre-filled syringe with 2ml content for single application. It contains 2% fermentative sodium hyaluronate (40mg/2ml), it is completely free from animal derived protein and therefore particularly well tolerated. 10mg Mannitol has been added in order to protect the sodium hyaluronate from premature degradation by free radicals, thus stabilising the solution and reducing the rate of deterioration (Mendoza 2007). OSTENIL® TENDON is injected around the affected tendon or into the tendon sheath.
Peter Hunt, Managing Director, said, “We are very excited about OSTENIL® TENDON and feel confident that it will benefit many people with impaired tendon function.”

Friday, 29 June 2012

Shoulders and Elbows

TRB Chemedica (UK) Ltd supported another event this summer related to sports medicine: the BESS Annual Scientific Meeting held in Torquay (15-17 June 2012). BESS stands for British Elbow and Shoulder Society.
The annual meeting in June attracted many delegates from all parts of the UK, to attend lectures and seminars on the techniques and latest developments in shoulder and elbow surgery and other treatment options.
TRB Chemedica (UK) Ltd had a stand at the trade exhibition during the congress, and TRB staff talked to many stand visitors about the benefits of sodium hyaluronate treatments for traumatic and degenerative joint disease in the shoulder and elbow.
OSTENIL® is the only Sodium Hyaluronate product recommended in the formulary for the world-wide sports event in England this year. This fact, coupled with the experience that many of the delegates already had with OSTENIL® and OSTENIL® PLUS, helped to promote the OSTENIL® range as a valid treatment option.
OSTENIL® and OSTENIL® PLUS come in the form of syringes which can be injected into the synovial joint either to prevent or to postpone surgery.
Sodium hyaluronate can also be used post-arthroscopy: VISCOSEAL® replaces the lost synovial fluid that was washed out during the arthroscopic procedure and helps to promote joint homeostasis.
We look forward to supporting other conferences later on in 2012 where we can talk to sports physicians and medical specialists about the benefits of the OSTENIL® range, and on how it can help rehabilitate our sporting champions.

Friday, 18 May 2012

New Packaging

We at TRB Chemedica are currently in the process of updating the packaging of our products. Our customers will have already noticed the new Vismed multi bottle which now comes in a new easy-to-use "Just squeeze" dispenser bottle. Vismed single-dose vials as well as Vismed light have also changed their appearance. Vismed gel will follow in 2-3 months' time.

In the orthopaedic product range used for the treatment of osteoarthritis, Ostenil Plus and Ostenil mini have also been transformed in appearance, with Ostenil to follow shortly. Ostenil Tendon is an exciting new product used for the treatment of tendinitis and already reflects the new packaging style.

Last but not least, Viscoseal now comes in a totally new presentation: in syringe form, which makes it easier to handle in the operating theatre.
Visit our website or contact us on for more details.

Monday, 14 May 2012

Sports Rehab & Trauma Conference 2012

Sports Rehab & Trauma Conference 2012
With the biggest sporting tournament on Earth about to come to London in the summer, there has been enormous interest from medical, surgical and rehabilitation specialists in the UK as to what tips and techniques clinical specialists from around the world might have to offer when it comes to keeping their athletes in tip top form.

At a very busy sports medicine and trauma meeting, held at Chelsea Football Club’s Stamford Bridge Football Ground, over 1000 delegates from all over Europe listened to presentations and seminars, given by some of the world’s leading sports physicians and surgeons, on rehabilitating sporting champions when they have picked up injuries.

The Isokinetic (International Conference on Sports Rehab’ and Trauma), which ran over 2 days (21-22 April 2012) was supported by TRB Chemedica (UK) Ltd, who had a trade exhibition stand at the event. Many of the problems raised by delegates visiting the stand related to maintaining optimum performance for athletes during arduous competitive seasons.  Traumatic and degenerative changes in articular joints are very common amongst top athletes, irrespective of which sport they play. Relieving pain and enhancing range of motion in articular joints are key factors in helping get these athletes back to peak form, and this was a theme that came up regularly in all the key presentations throughout the meeting.

The Ostenil Range of non-animal derived Sodium Hyaluronate injections, manufactured by TRB Chemedica, are specifically designed and licensed for the treatment of traumatic and degenerative changes in synovial joints. Not surprisingly, many of the specialist medical and physiotherapy delegates stated they already had experience with Ostenil and Ostenil Plus, and the fact that Ostenil is the only Sodium Hyaluronate product recommended in the formulary for the up - coming games reinforced their trust in the product range.

TRB Chemedica (UK) Ltd will be attending a host of sports medicine and surgical meetings throughout the rest of 2012, and our staff look forward to speaking with medical and rehabilitation specialists about the Ostenil range, and how it can help keep their patients at the top of their game!

Thursday, 26 January 2012

Viscoseal Roundtable Meeting

Synovial fluid replacement after arthroscopy

Arthroscopic procedures in shoulder, knee and hip are nowadays established as minimally invasive methods. However, post-operative pain, swelling and restricted mobility induced by tissue lesion cannot be completely avoided. Those post-operative symptoms can be alleviated with VISCOSEAL®, a solution of hyaluronic acid.

In January of 2011, Dr S Egger (Austria), Dr Muthu Jeyam (UK), Prof C Erggelet (Switzerland) and Dr W Weissenbacher (Austria) gathered together in Austria for a roundtable meeting, to discuss their experiences in arthroscopic surgery. A report on this meeting is now available on our website. Click here to read more...>>>